Yahoo Web Search

Search results

1. • Analyst Report: Coloplast A/S

     Morningstar Research via Yahoo Finance· 2 days ago

     Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment ...

2. • Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder...

     NBC 10 - FOX 14 Monroe· 6 days ago

     Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval ...

3. • 

     Bad Botox is on the market, FDA and CDC warn

     WAGA fox local articles via Yahoo News· 6 days ago

     Botox is, in part, the botulinum toxin that causes botulism. Used improperly, it can cause paralysis, trouble breathing and swallowing, dry mouth, ...

4. • Kimberly-Clark Co. (NYSE:KMB) Insider Doug Cunningham Sells 1,040 Shares of Stock

     ETF DAILY NEWS· 7 hours ago

     Kimberly-Clark Co. (NYSE:KMB – Get Free Report) insider Doug Cunningham sold 1,040 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an ...

5. • 

     FDA, CDC warn of side effects from fake Botox after 11 patients hospitalized

     WSOC via Yahoo News· 4 days ago

     WTVD reports there have been complaints in California, Colorado...and then once you do that, what...

6. • Kimberly-Clark (NYSE:KMB) PT Raised to $138.00 at UBS Group

     ETF DAILY NEWS· 6 days ago

     Kimberly-Clark (NYSE:KMB – Get Free Report) had its price objective raised by research analysts at UBS Group from $135.00 to $138.00 in a research note issued to investors on Wednesday, Benzinga ...

7. • Axonics, Inc. (NASDAQ:AXNX) Receives Consensus Rating of “Hold” from Brokerages

     ETF DAILY NEWS· 3 days ago

     Axonics, Inc. (NASDAQ:AXNX – Get Free Report) has been given a consensus rating of “Hold” by the thirteen research firms that are presently covering the company, MarketBeat Ratings reports.

8. • How Chronic Constipation Can Affect Your Health

     Mercola· 6 days ago

     For most people, an occasional bout of constipation is a minor aggravation. For many, the topic of their bowel movements is a private matter. While many people may have a bowel movement once ...

9. • Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024...

     Benzinga· 1 day ago

     Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine post-surgery

10. • AUA/SUFU Guideline on the Treatment of Overactive Bladder Allows Access to ReviTM System Earlier in...

      Coronado Eagle & Journal· 3 days ago

      BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of ReviTM, a patient-centric solution for urge urinary incontinence (UUI), ...